The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey

This publication has 32 references indexed in Scilit:

• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity
  Neuroscience Letters, 1988
• Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
  New England Journal of Medicine, 1988
• V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP+ concentrations and neurotoxicity
  Life Sciences, 1987
• Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum
  Life Sciences, 1987
• II. Selective accumulation of MPP+ in the substantia nigra: A key to neurotoxicity?
  Life Sciences, 1985
• Effects of 1‐Methyl‐4‐Phenyl‐1,2,5,6‐Tetrahydropyridine and Related Compounds on the Uptake of [³H]3,4‐Dihydroxyphenylethylamine and [³H]5‐Hydroxytryptamine in Neostriatal Synaptosomal Preparations
  Journal of Neurochemistry, 1985
• Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP
  Biochemical and Biophysical Research Communications, 1984
• Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson’s disease
  Neurochemical Pathology, 1983
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983